Photocure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

On February 8, 2022 Photocure ASA (OSE: PHO), The Bladder Cancer Company, reported that President and Chief Executive Officer, Dan Schneider and Chief Financial Officer, Erik Dahl will present a corporate overview and host 1-on-1 meetings with investors at the 11th Annual SVB Leerink Global Healthcare Conference, being held virtually February 14-18, 2022 (Press release, PhotoCure, FEB 8, 2022, View Source [SID1234607869]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Photocure’s presentation is scheduled to take place February 17th at 11:20am ET (5:20pm CET) and can be accessed via the link below: View Source